logo
Plus   Neg
Share
Email

Lear Corp. Boosts Capacity At AccuMED Facility To Produce Protective Masks

Lear Corp. (LEA) announced Monday it has added capacity at its AccuMED production facility, which specializes in the manufacturing of medical products, to produce protective masks to combat the coronavirus (COVID-19) pandemic.

The company has already donated masks recently to the Detroit Medical Center, the largest health care provider in southeast Michigan, and the City of Detroit for use by the police and fire departments.

Additionally, the Mocksville facility is currently designing and developing full face shield visors for production to support the health care response to the COVID-19 pandemic.

In February, Lear's Mocksville facility designed a facemask in response to a shortage of personal protective equipment in China. Lear then added production capacity for masks in less than 72 hours.

With cases of COVID-19 rising in other areas of the world, the operation has expanded from three production lines to seven, and now employs 200 people. Total capacity is 25,000 units per day, based on availability of raw materials.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Shares of Zoom Video Communications (ZM) gained 4% on extended session Tuesday after the video conferencing software company reported a first-quarter results that trumped Wall Street estimates and issued a outlook for the second and full year 2021 that is expected to beat current expectations. First-quarter... The National Retail Federation Chief Economist Jack Kleinhenz said it was too early to say how quickly or smoothly the U.S. economy would stage a recovery following the "sizable disruptions" due to the coronavirus pandemic. However, he noted that the reopening of businesses and the resumption of economic activity is a significant step forward. Following the recall of type 2 diabetes medication Metformin Hydrochloride Extended-Release (ER) by Apotex last week, the U.S. Food and Drug Administration or FDA has recommended more pharmaceutical companies, who are manufacturers of the drug formulation, to recall their products.
RELATED NEWS
Follow RTT